Oral Insulin Trial – ORMD-0801

Enroll Now

Type of Study:

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

Title of Study:

Oral Insulin Trial

Short Title:

ORMD-0801

Study Length: 12 Weeks

Target Age/Sex: 18 years and older with type 2 diabetes

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: Clinicaltrials.gov